Civica Appoints Dave Sehgal as Chief Manufacturing Officer and Supply Chain Officer

LEHI, Utah and PETERSBURG, Va., July 14, 2025 /PRNewswire/ -- Civica today announced the appointment of Dave Sehgal, Ph.D. as its new Chief Manufacturing Officer and Supply Chain Officer, effective July 21. In this role, Dr. Sehgal will lead Civica's manufacturing strategy and operations, reporting directly to Ned McCoy, President and CEO.

"We are excited to welcome Dave to our leadership team," said McCoy. "His deep expertise in pharmaceutical manufacturing and global operations will be instrumental as we continue to bring our Petersburg facility online and expand access to essential medicines."

Sehgal has nearly 30 years of experience in the pharmaceutical industry, having held leadership roles in the vaccines, biologics and small molecule manufacturing space.  He also has significant experience in technical services, quality and process development.  Dr. Sehgal succeeds Jay Benson.

"I am thrilled to join Civica at this time in the company's history," said Sehgal.  "I look forward to leading the team that will bring high-quality, essential generic medicines, manufactured in the United Sates to patients who need them."

Dr. Sehgal resides in Raleigh, NC and will be working closely with the Civica team at the company's manufacturing facility in Petersburg, Va.  The 140,000 square foot, state-of-the-art facility currently employs more than 200 skilled workers, with plans to hire another 60 employees by the end of 2025.  The facility has the capacity to manufacture 90 million vials, 50 million syringes and 120 million pre-filled pens of generic sterile injectable medicines every year.  The facility is in the final stages of certification by regulatory authorities and will be producing medicines for distribution in 2026.

Prior to joining Civica, Dr. Sehgal was the Vice President and Global Processing Engineering Head at CSL-Behring in Holly Springs, North Carolina.  In that role, he led a team of 500 scientists and engineers across four global sites in support of all CSL-Behring products.  Before CSL-Behring, Sehgal held leadership positions at FUJIFILM Diosynth Biotechnologies, Seqirus, Novartis, and Merck. Sehgal earned a bachelor's, master's, and doctoral degree in chemical engineering from NC State University.

This appointment reflects Civica's continued commitment to operational excellence and its mission to make quality generic medicines accessible and affordable for all.

About Civica
Civica is a nonprofit generic pharmaceutical company established to address drug shortages. It was founded by a group of U.S. health systems and philanthropies who, after more than a decade of chronic shortages, recognized that the market was not self-correcting and that a different approach is required. Civica works to deliver a safe, stable, and affordable supply of essential medicines to U.S. patients.

Media Contact
Liz Power, Vice President, Communications
[email protected]
860 501 3849

SOURCE CivicaRx